These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32002620)

  • 21. Genitourinary cancers: molecular determinants for personalized therapies.
    Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Raspollini MR; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Urologia; 2016 Sep; 83(3):107-109. PubMed ID: 27338983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical Care and Personalized or Precision Medicine: Who needs whom?
    Sugeir S; Naylor S
    J Crit Care; 2018 Feb; 43():401-405. PubMed ID: 29174462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences.
    Carrera PM; Ormond M
    Maturitas; 2015 Sep; 82(1):94-9. PubMed ID: 25981825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of precision medicine in the field of surgery].
    Deng A; Xiong R; Zeng C
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1662-5. PubMed ID: 26607096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Centralization in Denmark of diagnosis and treatment of tumors of the eye and surrounding tissues].
    Andersen SR
    Nord Med; 1965 Oct; 74(42):1054-7. PubMed ID: 5836671
    [No Abstract]   [Full Text] [Related]  

  • 26. Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review.
    Bowen RC; Ko HC; Avey GD; Hartig GK; Hu R; Harari PM; Lucarelli MJ
    Pract Radiat Oncol; 2019 May; 9(3):136-141. PubMed ID: 30731273
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances regarding the pathogenesis and treatment of ocular tumors.
    Int Ophthalmol Clin; 1980; 20(2):1-264. PubMed ID: 7399819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Personalized medicine: evolution or revolution?].
    Dekkers OM; Mook-Kanamori DO; Rosendaal FR
    Ned Tijdschr Geneeskd; 2016; 160():D606. PubMed ID: 27438398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of the complex treatment of tumors of the eye].
    Shkromida MI; Tsok RM
    Oftalmol Zh; 1986; (7):393-5. PubMed ID: 3822328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of intraocular tumors. (Review of the domestic and foreign literature)].
    Kotelianskiĭ EO
    Oftalmol Zh; 1965; 20(4):299-305 contd. PubMed ID: 5324079
    [No Abstract]   [Full Text] [Related]  

  • 31. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Options for management of intra ocular tumors.
    Lingam G
    Indian J Ophthalmol; 2015 Mar; 63(3):204-10. PubMed ID: 25971164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of intraocular tumors. (Review of the Soviet and foreign literature)].
    Kotelianskiĭ EO
    Oftalmol Zh; 1965; 20(5):371-82. PubMed ID: 5325888
    [No Abstract]   [Full Text] [Related]  

  • 34. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision medicine: In need of guidance and surveillance.
    Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
    World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges.
    Tavakolpour S
    Immunol Lett; 2017 Oct; 190():130-138. PubMed ID: 28797806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Multimodality Imaging Fusion Technology in Diagnosis and Treatment of Malignant Tumors under the Precision Medicine Plan.
    Wang SY; Chen XX; Li Y; Zhang YY
    Chin Med J (Engl); 2016 Dec; 129(24):2991-2997. PubMed ID: 27958232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The breakthrough of personalized medicine, new hopes and new challenges].
    Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
    Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Personalized Medicine Here?
    Carneiro BA; Costa R; Taxter T; Chandra S; Chae YK; Cristofanilli M; Giles FJ
    Oncology (Williston Park); 2016 Apr; 30(4):293-303, 307. PubMed ID: 27085327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.